Anti-CD20 therapy in systemic lupus erythematosus: A step closer to the clinic

被引：34

作者：

Silverman, GJ ^{[1
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

来源：

ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 02期

关键词：

D O I：

10.1002/art.20857

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：371 / 377

页数：7

共 41 条

[1] Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus [J].

Anolik, JH ;

Barnard, J ;

Cappione, A ;

Pugh-Bernard, AE ;

Felgar, RE ;

Looney, RJ ;

Sanz, I .

ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3580-3590

[2] The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus [J].

Anolik, JH ;

Campbell, D ;

Felgar, RE ;

Young, F ;

Sanz, I ;

Rosenblatt, J ;

Looney, RJ .

ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :455-459

[3] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].

BOMBARDIER, C ;

GLADMAN, DD ;

UROWITZ, MB ;

CARON, D ;

CHANG, CH .

ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640

[4] C1q, autoimmunity and apoptosis [J].

Botto, M ;

Walport, MJ .

IMMUNOBIOLOGY, 2002, 205 (4-5) :395-406

[5] RISK FOR SUSTAINED AMENORRHEA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING INTERMITTENT PULSE CYCLOPHOSPHAMIDE THERAPY [J].

BOUMPAS, DT ;

AUSTIN, HA ;

VAUGHAN, EM ;

YARBORO, CH ;

KLIPPEL, JH ;

BALOW, JE .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :366-369

[6] From the bench to the bedside: ways to improve rituximab efficacy [J].

Cartron, G ;

Watier, H ;

Golay, J ;

Solal-Celigny, P .

BLOOD, 2004, 104 (09) :2635-2642

[7] Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals [J].

Cassese, G ;

Arce, S ;

Hauser, AE ;

Lehnert, K ;

Moewes, B ;

Mostarac, M ;

Muehlinghaus, G ;

Szyska, M ;

Radbruch, A ;

Manz, RA .

JOURNAL OF IMMUNOLOGY, 2003, 171 (04) :1684-1690

[8] The central and multiple roles of B cells in lupus pathogenesis [J].

Chan, OTM ;

Madaio, MP ;

Shlomchik, MJ .

IMMUNOLOGICAL REVIEWS, 1999, 169 :107-121

[9] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].

Clynes, RA ;

Towers, TL ;

Presta, LG ;

Ravetch, JV .

NATURE MEDICINE, 2000, 6 (04) :443-446

[10] Sequential therapies for proliferative lupus nephritis [J].

Contreras, G ;

Pardo, V ;

Leclercq, B ;

Lenz, O ;

Tozman, E ;

O'Nan, P ;

Roth, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :971-980

← 1 2 3 4 5 →